1st Counsel – Lifestyle
Author:
Biodexa Pharmaceuticals PLC
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
April 2, 2026
Preliminary Results for the Year Ended 31 December 2025
March 30, 2026
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group
March 23, 2026
ADR Ratio Change
March 18, 2026
Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients
March 9, 2026